Key Points from Interview3 Sep 2025 11:03
● Discussions with new partners at various stages
● They were all looking forward to the patent filing.
● Patent would allow the partner to have 20 years exclusitivity without any competition which gives them pricing power and great revenues.
● Patent puts them in a strong position for negotiations for best deals.
● Deals would include upfront payments, milestone payments from time of deal up through to marketing and when drug is marketed.
● P140 offers 2 commercial opportunities, diagnostic side where market is worth $10 Billion annually, therapeutic side which market is worth $100billion per year.
● Next few weeks to pick up discussions
● Delivery of deals by end of year closing 1 or 2 deals across the portfoilio.
● No need for raise, as funding will be coming from deals; upfront payments and milestones.
P140 is groundbreaking which is a new innovative treatment. P140 being compared to Humira drug deal which was a game changer at that time. $Billion+ deal coming here have patience and be rewarded.